Minneapolis Heart Institute Foundation
Minneapolis Heart Institute Foundation
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for Minneapolis Heart Institute Foundation? Learn more here.
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.
About this organization
Mission
To improve the cardiovascular health of individuals and communities through innovative research and education.
About
RESEARCH: MHIF HAD MORE THAN 200 RESEARCH STUDIES UNDERWAY IN 2018, AS WELL AS MORE THAN 190 PEER-REVIEWED STUDIES AND MANUSCRIPTS PUBLISHED. MHIF RESEARCH PHYSICIANS, STAFF AND INTERNS GENERATED 87 ABSTRACTS AT NATIONAL AND INTERNATIONAL SCIENTIFIC MEETINGS AND PARTICIPATED IN 80 ORAL ABSTRACT OR PODIUM PRESENTATIONS AND INVITED TALKS. MHIF ACHIEVED GROWTH IN INDUSTRY-SPONSORED RESEARCH, INVESTIGATOR-INITIATED RESEARCH (DESIGNED AND LED BY LEADING PHYSICIANS), WITH REPRESENTATION ACROSS ALL SUBSPECIALTIES.SEVERAL OF THE RESEARCH STUDIES CONDUCTED AT MHIF IN 2018 INVOLVED GROUNDBREAKING TREATMENT APPROACHES AND TECHNOLOGIES. - MHIF ENROLLED THE FIRST PATIENT IN THE KPL STUDY (PHASE II FOR KINIKSA PHARMACEUTICALS) OF RILONACEPT FOR RECURRENT PERICARDITIS, INFLAMMATION OF THE PERICARDIUM (DOUBLE-WALLED SAC SURROUNDING THE HEART). DR. DAVID LIN AND TEAM ARE STUDYING THIS NEW OPTION FOR PATIENTS WHO HAVE SYMPTOMS DESPITE STANDARD THERAPY. - MHIF ENROLLED THE FIRST PATIENT IN THE VENT-AVOID TRIAL, RESEARCHING THE USE OF EXTRACORPOREAL CARBON DIOXIDE REMOVAL (ECCO2R) FOR TREATING PATIENTS WITH COPD EXACERBATIONS. - MHIF WAS THE TOP ENROLLER OUT OF 39 SITES AROUND THE WORLD AND SUCCESSFULLY COMPLETED ENROLLMENT OF PATIENTS IN THE FIRST COHORT OF THE RADIANCE-HTN STUDY. THIS STUDY IS EVALUATING A MINIMALLY INVASIVE, CATHETER-BASED PROCEDURE THAT MAY LOWER BLOOD PRESSURE AND REDUCE A PERSON'S NEED FOR MEDICATIONS. - MHIF ENROLLED THE FIRST PATIENT AND IS ONE OF ONLY EIGHT LEADING HEART CENTERS CONDUCTING THE ACCUCINCH STUDY, WHICH OFFERS A MINIMALLY INVASIVE TREATMENT OPTION FOR HEART FAILURE AND FUNCTIONAL MITRAL REGURGITATION PATIENTS WHO ARE UNLIKELY TO SURVIVE THE RISKS OF OPEN-HEART SURGERY.- MHIF RESEARCHER, DR. JOHN LESSER, SUE CASEY AND THEIR INVESTIGATOR-INITIATED RESEARCH TEAM WERE PART OF THE PROTECTION-IV STUDY PRESENTED AS A LATEBREAKER AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC) CONGRESS AND JOINTLY RELEASED IN THE EUROPEAN HEART JOURNAL. THIS STUDY ANALYZED THE RADIATION DOSE EXPOSURE OF CARDIAC COMPUTED TOMOGRAPHY ANGIOGRAPHIC STUDIES IN CURRENT DAILY PRACTICE WORLDWIDE.- MHIF RESEARCHER, DR. MARIO GOESSL ENROLLED THE FIRST PATIENT IN AN INVESTIGATOR-INITIATED STUDY HE DESIGNED TO BETTER UNDERSTAND RACIAL AND ETHNIC DISPARITIES IN THE TREATMENT OF HEART VALVE DISEASE.MHIF RESEARCH WAS RECOGNIZED IN THE COMMUNITY WITH SEVERAL OPPORTUNITIES TO DISCUSS RESEARCH AND ADVANCES IN CARDIOVASCULAR CARE ON LOCAL MEDIA. DR. KELLY HAN ALSO RECEIVED THE JON DEHAAN FOUNDATION AWARD FOR INNOVATION IN CARDIOLOGY IN RECOGNITION OF OUTSTANDING CONTRIBUTIONS TO IMPROVING BOTH SAFETY AND QUALITY OF IMAGING CONGENITAL HEART DISEASE IN ADULTS, CHILDREN AND INFANTS. AT THE TRANSCATHETER CARDIOVASCULAR THERAPEUTICS (TCT) CONFERENCE, MHIF RESEARCH FELLOW, DR. PETER TAJTI, TOOK SECOND PLACE IN THE INTERNATIONAL FELLOWS CHALLENGING CASE SESSION.
Interesting data from their 2020 990 filing
According to the filing, the non-profit's mission is “The mission of the minneapolis heart institute foundation is to improve the cardiovascular health of individuals and communities through innovative research and education.”.
When referring to its actions, they were described as: “To improve the cardiovascular health of individuals and communities through innovative research and education.”.
- According to the law, the state of operation reported by the non-profit is MN.
- As per the filing, the address of the non-profit for 2020 is 920 E 28TH STREET NO 100, MINNEAPOLIS, MN, 554071191.
- According to their form, the non-profit as of 2020 has a total of 103 employees.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is $1,216,249.
- The organization has 34 independent voting members.
- The organization was formed in 1982.
- The organization pays $7,002,168 in salary, compensation, and benefits to its employees.
- The organization pays $1,136,672 in fundraising expenses.